Quanterix

Company Overview

Quanterix is a U.S.-based company specializing in ultra-sensitive biomarker detection and analytical technologies for research and clinical applications. It develops and commercializes advanced immunoassay platforms that enable precise quantification of low-abundance proteins and other biomarkers, addressing critical needs in drug development, disease monitoring, and translational research. It serves pharmaceutical, biotechnology, and academic clients, providing solutions that support both preclinical studies and clinical trials across multiple therapeutic areas, including neurology, oncology, and immunology.

Financial Highlights (FY 2025)

Company's Business Segments

• Product Revenue : This segment includes Instruments, Consumable Products, Other Products.
• Service and Other Revenue : This segment includes Service-type Warranties, Research Services, Other Services.
• Collaboration and License Revenue : Collaboration and license revenues consist of licensing company Technology, Intellectual Property, Know-how Associated with instruments to Third Parties, for Related Services.
• Grant Revenue : Grant revenues consist of funding received to perform specific research and development services under grant arrangements.